US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Biogen

117.76

+1.271.09%

Volume:100.26K

Turnover:11.87M

Market Cap:17.24B

PE:10.53

High:119.72

Open:118.12

Low:117.40

Close:116.49

Loading ...

Overview Company News Filings

IONS Out-Licenses ex-U.S. Rights for Rare Disease Drug Tryngolza to Sobi

SAVA Stock Down as Alzheimer's Drug Fails in Second Late-Stage Study

Biogen Inc. Stock Underperforms Tuesday When Compared To Competitors

Biogen Signs Lease for New Global HQ in Cambridge, Massachusetts

MT Newswires Live

BRIEF-Biogen Announces Plans For New Global Headquarters And Innovation Hub In Kendall Square

Biogen Announces Plans for New Global Headquarters and Innovation Hub in Kendall Square

THOMSON REUTERS

Biogen Inc - to Relocate Cambridge-Based Employees to New Site in 2028

THOMSON REUTERS

Biogen Announces Plans for New Global Headquarters and Innovation Hub in Kendall Square

Q4 Rundown: Moderna (NASDAQ:MRNA) Vs Other Therapeutics Stocks

Biogen Inc. Stock Underperforms Wednesday When Compared To Competitors

Novartis New Data From Single-Dose Gene Therapy Shows Meaningful Efficacy, Safety In Patients With Spinal Muscular Atrophy

Robinhood, Home Depot, and More Stocks for the 'Silver Tsunami' of Older Shoppers -- Barrons.com

BRIEF-Biogen Canada's Skyclarys Approved By Health Canada To Treat Friedreich's Ataxia In Patients 16 Years Of Age And Older

Why Is Biogen (BIIB) Up 1.1% Since Last Earnings Report?

Can BIIB's New Drugs Revive Growth as Multiple Sclerosis Sales Fall?

Biogen Inc. Stock Underperforms Tuesday When Compared To Competitors

Biogen Initiates Dosing of Phase 3 Study of Felzartamab

MT Newswires Live

IONS/AZN Get FDA Nod for Amyloidosis Drug, Wainzua in Europe

Biogen announces initiation of dosing in TRANSCEND

Biogen Initiates Phase 3 Study of Felzartamab for the Treatment of Late Antibody-Mediated Rejection (AMR) in Kidney Transplant Patients

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/BIIB/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BIIB","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BIIB\",,,,,undefined,":{"symbol":"BIIB","market":"US","secType":"STK","nameCN":"Biogen","latestPrice":117.76,"timestamp":1745331745993,"preClose":116.49,"halted":0,"volume":100257,"delay":0,"floatShares":146001885,"shares":146374937,"eps":11.18,"marketStatus":"Trading","change":1.27,"latestTime":"04-22 10:22:28 EDT","open":118.12,"high":119.715,"low":117.3961,"amount":11869792.168049999,"amplitude":0.019906,"askPrice":117.78,"askSize":161,"bidPrice":117.66,"bidSize":18,"shortable":3,"etf":0,"ttmEps":11.18,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1745352000000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":685080000000,"exchange":"NASDAQ","adjPreClose":116.49,"preHourTrading":{"tag":"盘前","latestPrice":118.03,"preClose":116.49,"latestTime":"09:29 EDT","volume":796,"amount":93487.95528000001,"timestamp":1745328599999},"postHourTrading":{"tag":"盘后","latestPrice":116.49,"preClose":116.49,"latestTime":"19:52 EDT","volume":455328,"amount":53041299.68,"timestamp":1745279553238},"volumeRatio":0.525243,"impliedVol":0.47,"impliedVolPercentile":0.936},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BIIB\",,,,,undefined,":{"symbol":"BIIB","floatShares":146001885,"roa":"5.29%","roe":"10.36%","lyrEps":11.210164,"volumeRatio":0.525243,"shares":146374937,"dividePrice":0,"high":119.715,"amplitude":0.019906,"preClose":116.49,"low":117.3961,"week52Low":110.035,"pbRate":"1.03","psRate":"1.78","week52High":238,"institutionHeld":0.8231,"latestPrice":117.76,"committee":-0.798883,"eps":11.18,"divideRate":0,"volume":100257,"delay":0,"ttmEps":11.18,"open":118.12,"prevYearClose":152.92,"prevWeekClose":118.61,"prevMonthClose":136.84,"prevQuarterClose":136.84,"fiveDayClose":119.26,"twentyDayClose":141.6,"sixtyDayClose":146.2,"earningDate":1746028800000,"earningTime":"盘前"},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BIIB\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2522304112","title":"IONS Out-Licenses ex-U.S. Rights for Rare Disease Drug Tryngolza to Sobi","url":"https://stock-news.laohu8.com/highlight/detail?id=2522304112","media":"Zacks","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522304112?lang=en_us&edition=fundamental","pubTime":"2025-03-27 20:31","pubTimestamp":1743078660,"startTime":"0","endTime":"0","summary":"Ionis Pharmaceuticals IONS signed a license agreement with Sweden-based Sobi. Per the terms, Sobi will acquire exclusive rights to market its wholly owned drug Tryngolza outside the United States .The FDA recently approved Tryngolzafor treating familial chylomicronemia syndrome , a rare genetic disease marked by extremely elevated triglyceride levels. This nod makes the drug the first approved treatment for FCS in the country.Italso marks Ionis’ first independent commercial launch. A regulatory filing for this FCS drug is currently under review by the EMA, with a final decision expected later this year.Per the deal terms, Sobi will be responsible for all future regulatory filings and commercialization activities for the drug in ex-U.S.geographies exceptCanada andChina. Ionis will continue to market the drug in the United States independently.In consideration of granting these rights, Ionis will receive an undisclosed upfront payment and be eligible for milestone payments. The company w","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/ions-licenses-ex-u-rights-123100545.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1829250122.USD","LU0889565916.HKD","BK4585","LU2417539215.USD","LU2236285917.USD","GSK","LU2456880835.USD","BIIB","IE00B19Z9P08.USD","GSK.UK","BK4588","BK4532","CHB","LU0109394709.USD","LU2462157665.USD","BK4533","BK4568","IONS","AZN","IE00B19Z9Z06.USD","IE00B894F039.SGD","BK4139","BK4007","LU0320765992.SGD","LU0234570918.USD"],"gpt_icon":0},{"id":"2522880492","title":"SAVA Stock Down as Alzheimer's Drug Fails in Second Late-Stage Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2522880492","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522880492?lang=en_us&edition=fundamental","pubTime":"2025-03-26 19:43","pubTimestamp":1742989380,"startTime":"0","endTime":"0","summary":"Shares of Cassava Sciences SAVA plunged 32.1% on Tuesday after the company announced that its lead pipeline candidate, simufilam, failed to meet the prespecified co-primary endpoints in the second late-stage study for Alzheimer’s disease . Simufilam is SAVA’s proprietary, investigational oral small molecule that targets the filamin A protein.Cassava released top-line results from the phase III REFOCUS-ALZ study, which evaluated simufilam in patients with mild-to-moderate AD. Treatment with the drug failed to achieve a significant reduction in cognitive and functional decline in AD patients when compared to placebo over 76 weeks, as assessed by the ADAS-COG12 and ADCS-ADL scales. The study also failed to meet any pre-specified secondary and exploratory biomarker endpoints.The REFOCUS-ALZ study had enrolled 1,125 AD patients who were randomized equally to receive either a twice-daily, oral dose of simufilam  or placebo for 76 weeks. The candidate, however, demonstrated an acceptable safe","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/sava-stock-down-alzheimers-drug-114300226.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0096364046.USD","BK4547","BK4532","IE00BK4W5M84.HKD","LU1988902786.USD","BK4581","BK4566","LU1057294990.SGD","LLY","SG9999001176.USD","IE00B1BXHZ80.USD","IE00BJLML261.HKD","SAVAW","SG9999017495.SGD","LU0640476718.USD","LU1093756325.SGD","GILD","IE0004445239.USD","LU0094547139.USD","SG9999013999.USD","LU1291159041.SGD","LU1868837136.USD","LU2265009873.SGD","SSI","SG9999015986.USD","LU1280957306.USD","BK4583","BIIB","SGXZ51526630.SGD","LU0466842654.USD","LU1917777945.USD","SAVA","LU2461242641.AUD","LU2106854487.HKD","IE00BJJMRZ35.SGD","LU0006306889.USD","LU1093756168.USD","LU0820561909.HKD","LU2360106947.USD","SGXZ81514606.USD","SG9999001176.SGD","LU2491050071.SGD","LU1839511570.USD","SG9999014914.USD","BK4007","LU0198837287.USD","LU2112291526.USD","LU0109394709.USD","LU1989771016.USD","LU0114720955.EUR","LU0203202063.USD"],"gpt_icon":0},{"id":"2522835621","title":"Biogen Inc. Stock Underperforms Tuesday When Compared To Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2522835621","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522835621?lang=en_us&edition=fundamental","pubTime":"2025-03-26 05:08","pubTimestamp":1742936880,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Biogen Inc.  slipped 1.72% to $139.16 Tuesday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index  rising 0.16% to 5,776.65 and the Dow Jones Industrial Average  rising 0.01% to 42,587.50.Biogen Inc. closed 41.53% short of its 52-week high of $238.00, which the company achieved on July 12th.The stock demonstrated a mixed performance when compared to some of its competitors Tuesday, as Johnson & Johnson  fell 1.39% to $161.02, Pfizer Inc.  fell 2.26% to $25.55, and AbbVie Inc.  fell 3.74% to $201.34.Trading volume  eclipsed its 50-day average volume of 1.6 M.Data source: Dow Jones Market Data, FactSet. Data compiled March 25, 2025.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIIB"],"gpt_icon":0},{"id":"2521724360","title":"Biogen Signs Lease for New Global HQ in Cambridge, Massachusetts","url":"https://stock-news.laohu8.com/highlight/detail?id=2521724360","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521724360?lang=en_us&edition=fundamental","pubTime":"2025-03-24 21:32","pubTimestamp":1742823139,"startTime":"0","endTime":"0","summary":"Biogen  said Monday it has signed a 15-year lease for its new global headquarters at Kendall Common in Cambridge, Massachusetts.The company said it intends to shift its Cambridge-based employees to the new facility when it opens in 2028.Biogen said it will integrate its research and development and technical operations teams alongside its global and North American commercial organizations into a co-located innovation hub, adding that the lease deal is with a new joint venture collaboration between MIT Investment Management and Blackstone  Real Estate portfolio company BioMed Realty, which is constructing the new building.Price: 141.36, Change: +0.46, Percent Change: +0.33","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE00BLSP4452.SGD","IE00BN8TJ469.HKD","IE00BBT3K403.USD","BX","LU0109394709.USD","IE00B894F039.SGD","BK4532","BK4533","BIIB","BK4135","IE00B64PRP62.GBP","LU0889565916.HKD","LU0234570918.USD","LU0320765992.SGD","BK4588","BK4585","BK4139","IE00BGHQF748.EUR","IE00BLSP4239.USD","IE00B19Z9P08.USD","IE0004445239.USD","IE00B19Z9Z06.USD","IE00B3QW5Z07.USD"],"gpt_icon":0},{"id":"2521445717","title":"BRIEF-Biogen Announces Plans For New Global Headquarters And Innovation Hub In Kendall Square","url":"https://stock-news.laohu8.com/highlight/detail?id=2521445717","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521445717?lang=en_us&edition=fundamental","pubTime":"2025-03-24 19:38","pubTimestamp":1742816292,"startTime":"0","endTime":"0","summary":"BRIEF-Biogen Announces Plans For New Global Headquarters And Innovation Hub In Kendall SquareBiogen Inc BIIB.O:BIOGEN ANNOUNCES PLANS FOR NEW GLOBAL HEADQUARTERS AND INNOVATION HUB IN KENDALL SQUARESource text: ID:nGNED6z6VFurther company coverage: BIIB.O","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250324:nFWN3Q70VB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","LU0109394709.USD","IE00B19Z9P08.USD","BK4532","BK4588","BK4139","BK4533","LU0320765992.SGD","BIIB","IE00B19Z9Z06.USD","LU0234570918.USD","LU0889565916.HKD","IE00B894F039.SGD"],"gpt_icon":0},{"id":"2521744815","title":"Biogen Announces Plans for New Global Headquarters and Innovation Hub in Kendall Square","url":"https://stock-news.laohu8.com/highlight/detail?id=2521744815","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521744815?lang=en_us&edition=fundamental","pubTime":"2025-03-24 19:31","pubTimestamp":1742815907,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250324:nFWN3Q70VB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BIIB","IE00B19Z9Z06.USD","IE00B19Z9P08.USD","BK4532","LU0234570918.USD","BK4533","BK4585","BK4588","LU0320765992.SGD","IE00B894F039.SGD","LU0889565916.HKD","LU0109394709.USD","BK4139"],"gpt_icon":0},{"id":"2521448197","title":"Biogen Inc - to Relocate Cambridge-Based Employees to New Site in 2028","url":"https://stock-news.laohu8.com/highlight/detail?id=2521448197","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521448197?lang=en_us&edition=fundamental","pubTime":"2025-03-24 19:31","pubTimestamp":1742815889,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250324:nFWN3Q71BA:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BIIB","BK4533","BK4588","IE00B894F039.SGD","IE00B19Z9P08.USD","IE00B19Z9Z06.USD","LU0320765992.SGD","LU0889565916.HKD","LU0109394709.USD","BK4585","LU0234570918.USD","BK4532"],"gpt_icon":0},{"id":"2521474431","title":"Biogen Announces Plans for New Global Headquarters and Innovation Hub in Kendall Square","url":"https://stock-news.laohu8.com/highlight/detail?id=2521474431","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521474431?lang=en_us&edition=fundamental","pubTime":"2025-03-24 19:30","pubTimestamp":1742815800,"startTime":"0","endTime":"0","summary":"Biogen signs lease for Kendall Common as part of multi-year real estate optimization plan to modernize its facilities and consolidate its Massachusetts real estate footprintNew building will be design","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/03/24/3047737/0/en/Biogen-Announces-Plans-for-New-Global-Headquarters-and-Innovation-Hub-in-Kendall-Square.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4533","IE00B19Z9P08.USD","IE00B19Z9Z06.USD","BK4585","LU0889565916.HKD","IE0031619046.USD","HUBG","BK4588","BIIB","BK4139","IE00B19Z4B17.USD","LU0320765992.SGD","LU0234570918.USD","IE00B66KJ199.SGD","BK4532","BK4131","IE00B7SZL793.SGD","LU0109394709.USD","IE00B894F039.SGD"],"gpt_icon":0},{"id":"2521717287","title":"Q4 Rundown: Moderna (NASDAQ:MRNA) Vs Other Therapeutics Stocks","url":"https://stock-news.laohu8.com/highlight/detail?id=2521717287","media":"StockStory","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521717287?lang=en_us&edition=fundamental","pubTime":"2025-03-24 17:01","pubTimestamp":1742806869,"startTime":"0","endTime":"0","summary":"Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Moderna  and the best and worst performers in the therapeutics industry.Over the next few years, therapeutic companies, which develop a wide variety of treatments for diseases and disorders, face strong tailwinds from advancements in precision medicine  and growing demand for treatments targeting rare diseases. However, headwinds such as rising scrutiny over drug pricing, regulatory unknowns, and competition from larger, more resourced pharmaceutical companies could weigh on growth.The 10 therapeutics stocks we track reported a satisfactory Q4. As a group, revenues beat analysts’ consensus estimates by 2.6%.In light of this news, share prices of the companies have held steady. On average, they are relatively unchanged since the latest earnings results.Rising to global prominence during the COVID-19 pandemic with one of the first ef","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/q4-rundown-moderna-nasdaq-mrna-090109783.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0234572021.USD","NQmain","LU0965509010.AUD","USJW.SI","LU0234570918.USD","LU1244550494.USD","LU0456855351.SGD","NVIW.SI","LU2089283258.USD","IE00BFTCPJ56.SGD","SG9999003800.SGD","IE0009355771.USD","LU0965508806.USD","MNQmain","LU1934455194.USD","NDAQ","MRNA","IE00B19Z3B42.SGD","LU0985320562.USD","BMRN","LU1267930490.SGD","ABBV","IE0002141913.USD",".IXIC","IE00B64PRP62.GBP","TSYW.SI","LU1244550577.SGD","BK4533","BK4550","LU0417517546.SGD","LU2129689514.USD","BK4551","LENZ","IE00B3QW5Z07.USD","LU1585245621.USD","QLD","BK4534","USAW.SI","LU0203347892.USD","SG9999015986.USD","LU0158827948.USD","LU2237443622.USD","SRPT","PSQ","QID","SQQQ","BIIB","IE00BDGV0183.EUR","TQQQ"],"gpt_icon":1},{"id":"2520191585","title":"Biogen Inc. Stock Underperforms Wednesday When Compared To Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2520191585","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520191585?lang=en_us&edition=fundamental","pubTime":"2025-03-20 05:07","pubTimestamp":1742418420,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Biogen Inc.  shed 1.16% to $141.43 Wednesday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index  rising 1.08% to 5,675.29 and the Dow Jones Industrial Average  rising 0.92% to 41,964.63.This was the stock's second consecutive day of losses.Biogen Inc. closed 40.58% below its 52-week high of $238.00, which the company achieved on July 12th.The stock underperformed when compared to some of its competitors Wednesday, as Johnson & Johnson  fell 0.77% to $162.99, Pfizer Inc.  fell 0.38% to $26.21, and AbbVie Inc.  fell 0.75% to $212.25.Trading volume  remained 384,922 below its 50-day average volume of 1.6 M.Data source: Dow Jones Market Data, FactSet. Data compiled March 19, 2025.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall S","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIIB"],"gpt_icon":0},{"id":"2520168133","title":"Novartis New Data From Single-Dose Gene Therapy Shows Meaningful Efficacy, Safety In Patients With Spinal Muscular Atrophy","url":"https://stock-news.laohu8.com/highlight/detail?id=2520168133","media":"Benzinga","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520168133?lang=en_us&edition=fundamental","pubTime":"2025-03-20 01:09","pubTimestamp":1742404163,"startTime":"0","endTime":"0","summary":"On Wednesday, Novartis AG  announced safety and efficacy results from the Phase 3 program for investigational intrathecal onasemnogene abeparvovec  in a broad population of patients aged two to <18 years with spinal muscular atrophy .In the Phase 3 STEER study, treatment with OAV101 IT led to a statistically significant 2.39-point improvement on the Hammersmith Functional Motor Scale Expanded , an assessment of motor ability and disease progression, vs. 0.51 points in the sham control arm.Also Read: Novartis To Beef Up Heart Disease Offering With $3 Billion Blackstone-Backed Anthos Therapeutics Deal. Novartis released topline data from the Phase 3 STEER study in December 2024.The results add to the growing body of evidence within the OAV101 IT development program, which has evaluated a broad population of over 170 patients with SMA, spanning a total of over 6.4 years across the STEER, STRENGTH, and Phase 1/2 STRONG studies.In the registrational STEER study, efficacy and safety were stu","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/novartis-data-single-dose-gene-170923739.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE00B894F039.SGD","NVS","LU0889565916.HKD","LU0109394709.USD","IE00B4R5TH58.HKD","LU0320765992.SGD","IE00BJT1NW94.SGD","IE00B2B36J28.USD","LU0208291251.USD","BK4578","BK4139","IE0002141913.USD","LU0070302665.USD","LU0320765489.SGD","BIIB","BK4585","IE0009355771.USD","BK4533","BK4007","IE00B19Z9Z06.USD","IE00B19Z9P08.USD","BK4532","BK4588","LU0211331839.USD","LU0234570918.USD","IE00BJJMRZ35.SGD","IE00BFTCPJ56.SGD"],"gpt_icon":0},{"id":"2520503103","title":"Robinhood, Home Depot, and More Stocks for the 'Silver Tsunami' of Older Shoppers -- Barrons.com","url":"https://stock-news.laohu8.com/highlight/detail?id=2520503103","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520503103?lang=en_us&edition=fundamental","pubTime":"2025-03-18 01:26","pubTimestamp":1742232360,"startTime":"0","endTime":"0","summary":"Winners and losers are set to emerge from the \"Silver Tsunami\" as an aging population triggers profound changes across multiple sectors, Mizuho analysts say.People who are 75 and older will compose 10% of the total population in the U.S. by 2030, representing a 7.5% increase from current numbers. Based on Mizuho's analysis, total spending among this age group could surge from $900 billion in 2023 to $1.6 trillion to 2030.The Silver Tsunami refers to baby boomers born between 1946 and 1964 reaching retirement age. \"Corporate America still needs to focus on this shift, and AI  will be a differentiator,\" the analysts wrote.Mizuho identified 11 stocks that have the most room to rise. The list ranges from the home improvement retailer Home Depot to the stock-trading platform Robinhood Markets and the pharmaceutical company Biogen. Certain spending categories are expected to emerge as \"net winners\" and \"net challenged\" as the U.S. population ages, the analysts said.Mizuho nodded to Biogen, w","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LU0154245673.USD","BK4532","LU0079474960.USD","BK4225","LU0109394709.USD","IE00BWXC8680.SGD","LU1551013342.USD","LU0820561818.USD","LU0823434740.USD","LU1894683264.USD","IE00BKVL7J92.USD","HD","LU0124676726.USD","IE00B19Z9Z06.USD","BK4588","LU2756315318.SGD","LU1674673428.USD","LU0320765992.SGD","BK4504","LU0354030438.USD","LU1093756168.USD","LU1162221912.USD","IE00B1XK9C88.USD","LU1496350502.SGD","HOOD","IE00BSNM7G36.USD","LU1551013425.SGD","ROK","BIIB","IE00BZ1G4Q59.USD","BK4585","BK4083","CFA.SI","IE00B19Z9P08.USD","LU0689626769.HKD","LU0820562030.AUD","VTR","WELL","LU0390134368.USD","LU0823411888.USD","LU0868494617.USD","LU0234570918.USD","BK4580","LU1929549753.HKD","LU0234572021.USD","BK4534","LU0943347566.SGD","LU2756315664.SGD","IE00B894F039.SGD"],"gpt_icon":1},{"id":"2520754165","title":"BRIEF-Biogen Canada's Skyclarys Approved By Health Canada To Treat Friedreich's Ataxia In Patients 16 Years Of Age And Older","url":"https://stock-news.laohu8.com/highlight/detail?id=2520754165","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520754165?lang=en_us&edition=fundamental","pubTime":"2025-03-17 19:18","pubTimestamp":1742210296,"startTime":"0","endTime":"0","summary":"BRIEF-Biogen Canada's Skyclarys Approved By Health Canada To Treat Friedreich's Ataxia In Patients 16 Years Of Age And OlderMarch 17 (Reuters) - Biogen Inc BIIB.O:BIOGEN CANADA: HEALTH CANADA APPROVES","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250317:nFWN3Q00HJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0109394709.USD","LU0320765992.SGD","IE00B894F039.SGD","IE00B19Z9Z06.USD","LU0234570918.USD","LU0889565916.HKD","IE00B19Z9P08.USD","BK4533","BK4532","BIIB","BK4585","BK4588","BK4139"],"gpt_icon":0},{"id":"2519438089","title":"Why Is Biogen (BIIB) Up 1.1% Since Last Earnings Report?","url":"https://stock-news.laohu8.com/highlight/detail?id=2519438089","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519438089?lang=en_us&edition=fundamental","pubTime":"2025-03-14 23:30","pubTimestamp":1741966235,"startTime":"0","endTime":"0","summary":"It has been about a month since the last earnings report for Biogen Inc. . Shares have added about 1.1% in that time frame, outperforming the S&P 500.Will the recent positive trend continue leading up to its next earnings release, or is Biogen due for a pullback?Before we dive into how investors and analysts have reacted as of late, let's take a quick look at the most recent earnings report in order to get a better handle on the important drivers.It turns out, estimates review have trended downward during the past month.The consensus estimate has shifted -9.02% due to these changes.At this time, Biogen has a subpar Growth Score of D, however its Momentum Score is doing a bit better with a C. However, the stock was allocated a grade of A on the value side, putting it in the top 20% for this investment strategy.Biogen is part of the Zacks Medical - Biomedical and Genetics industry. Over the past month, Gilead Sciences , a stock from the same industry, has gained 7%. The company reported ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/why-biogen-biib-1-1-153035548.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BIIB","GILD"],"gpt_icon":0},{"id":"2519551386","title":"Can BIIB's New Drugs Revive Growth as Multiple Sclerosis Sales Fall?","url":"https://stock-news.laohu8.com/highlight/detail?id=2519551386","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519551386?lang=en_us&edition=fundamental","pubTime":"2025-03-14 21:40","pubTimestamp":1741959600,"startTime":"0","endTime":"0","summary":"Sales of Biogen’s BIIB key multiple sclerosis  drugs like Tecfidera and Tysabri and spinal muscular atrophy  treatment, Spinraza, are being hurt due to competitive pressure, which is resulting in declining total revenues. Biogen’s total revenues declined 2% in 2024. In 2025, total revenues are expected to decline by a mid-single-digit percentage in constant currency terms.Sales of MS drugs and Spinraza are declining due to competitive pressure. Tecfidera revenues are declining as multiple generic versions have been launched in North America, Brazil and certain European countries. Regulatory applications seeking approval for a biosimilar referencing Tysabri have been approved in the United States and Europe. Regulatory applications seeking approval for a biosimilar referencing Tysabri have been approved in both the United States and Europe. A Tysabri biosimilar is now available in some European countries and this is hurting growth. Additional launches in other EU countries and in the Un","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/biibs-drugs-revive-growth-multiple-134000374.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BIIB"],"gpt_icon":0},{"id":"2518777440","title":"Biogen Inc. Stock Underperforms Tuesday When Compared To Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2518777440","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518777440?lang=en_us&edition=fundamental","pubTime":"2025-03-12 05:06","pubTimestamp":1741727160,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Biogen Inc.  slid 4.68% to $143.66 Tuesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index  falling 0.76% to 5,572.07 and Dow Jones Industrial Average  falling 1.14% to 41,433.48.The stock's fall snapped a seven-day winning streak.Biogen Inc. closed 39.64% below its 52-week high of $238.00, which the company achieved on July 12th.The stock underperformed when compared to some of its competitors Tuesday, as Johnson & Johnson  fell 1.10% to $165.86, Pfizer Inc.  fell 2.44% to $25.99, and AbbVie Inc.  fell 1.42% to $213.59.Trading volume  eclipsed its 50-day average volume of 1.5 M.Data source: Dow Jones Market Data, FactSet. Data compiled March 11, 2025.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIIB"],"gpt_icon":0},{"id":"2518874459","title":"Biogen Initiates Dosing of Phase 3 Study of Felzartamab","url":"https://stock-news.laohu8.com/highlight/detail?id=2518874459","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518874459?lang=en_us&edition=fundamental","pubTime":"2025-03-11 21:46","pubTimestamp":1741700784,"startTime":"0","endTime":"0","summary":"Biogen  said Tuesday that it has initiated dosing in the phase 3 Transcend study of felzartamab to treat adult kidney transplant recipients diagnosed with late antibody-mediated rejection, or late AMR.The biotech company said the study, which will evaluate the efficacy and safety of the investigational drug felzartamab compared to placebo, will enroll approximately 120 kidney transplant recipients with late AMR.The primary endpoint of study is the percentage of participants who achieve resolution by biopsy of AMR at 6 months.Price: 149.33, Change: -1.38, Percent Change: -0.92","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE00B894F039.SGD","IE00B19Z9Z06.USD","BK4139","BK4533","BK4588","BK4585","LU0889565916.HKD","LU0320765992.SGD","IE00B19Z9P08.USD","BK4532","LU0109394709.USD","BIIB","LU0234570918.USD"],"gpt_icon":0},{"id":"2518723100","title":"IONS/AZN Get FDA Nod for Amyloidosis Drug, Wainzua in Europe","url":"https://stock-news.laohu8.com/highlight/detail?id=2518723100","media":"Zacks","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518723100?lang=en_us&edition=fundamental","pubTime":"2025-03-11 20:43","pubTimestamp":1741696980,"startTime":"0","endTime":"0","summary":"Ionis Pharmaceuticals IONS announced that the European Commission  has approved Wainzua  for treating adult patients with hereditary transthyretin-mediated amyloidosis with stage 1 or stage 2 polyneuropathy . The drug has been developed in partnership with AstraZeneca AZN.This approval was expected as the EMA’s Committee for Medicinal Products for Human Use  issued a positive opinion recommending the approval of Wainzua in the above indication in October.The EC and CHMP decisions are based on positive data from the phase III NEURO-TTRansform study, which evaluated the safety and efficacy of Wainzua in patients with ATTRv-PN. Data from this study showed that treatment with the drug led to consistent and sustained benefit in the co-primary endpoints of serum transthyretin  concentration and neuropathy impairment. Treatment with Wainzua also improved quality of life versus placebo, a key secondary endpoint of the NEURO-TTRansform study.ATTRv-PN is a debilitating disease,which leads to per","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/ions-azn-fda-nod-amyloidosis-124300822.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","LU1169589451.USD","LU2456880835.USD","HAE","IE00B19Z9P08.USD","LU2236285917.USD","CHB","BK4568","IE00B894F039.SGD","GSK.UK","AZN","LU1169590202.USD","IE00B64QTZ34.USD","IE00BLDYK493.USD","LU0109394709.USD","LU2462157665.USD","BK4532","BK4007","BK4533","LU0205193047.USD","BK4588","LU0205194284.USD","LU2417539215.USD","LU0012050646.USD","BK4585","IE00B19Z9Z06.USD","LU0234570918.USD","LU0889565916.HKD","LU1829250122.USD","BIIB","IONS","GSK","BK4198","LU0106261612.USD","LU0320765992.SGD"],"gpt_icon":0},{"id":"2518610748","title":"Biogen announces initiation of dosing in TRANSCEND","url":"https://stock-news.laohu8.com/highlight/detail?id=2518610748","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518610748?lang=en_us&edition=fundamental","pubTime":"2025-03-11 19:40","pubTimestamp":1741693247,"startTime":"0","endTime":"0","summary":"Biogen (BIIB) announced the initiation of dosing in the global clinical study, TRANSCEND. The Phase 3 study will evaluate the efficacy and safety o...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/biogen-announces-initiation-of-dosing-in-transcend?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/biogen-announces-initiation-of-dosing-in-transcend?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0109394709.USD","LU0889565916.HKD","BIIB","IE00B19Z9P08.USD","BK4533","BK4585","IE00B894F039.SGD","BK4588","BK4532","BK4139","LU0320765992.SGD","IE00B19Z9Z06.USD","LU0234570918.USD"],"gpt_icon":0},{"id":"2518177597","title":"Biogen Initiates Phase 3 Study of Felzartamab for the Treatment of Late Antibody-Mediated Rejection (AMR) in Kidney Transplant Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2518177597","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518177597?lang=en_us&edition=fundamental","pubTime":"2025-03-11 19:30","pubTimestamp":1741692600,"startTime":"0","endTime":"0","summary":"Global Phase 3 TRANSCEND study will evaluate the efficacy and safety of felzartamab, as compared to placebo, in adults with late AMRAMR is a leading cause of kidney transplant loss, with approximately","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/03/11/3040447/0/en/Biogen-Initiates-Phase-3-Study-of-Felzartamab-for-the-Treatment-of-Late-Antibody-Mediated-Rejection-AMR-in-Kidney-Transplant-Patients.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4532","BK4006","LU0109394709.USD","LU0234570918.USD","BK4585","BK4533","LU0320765992.SGD","IE00B19Z9P08.USD","BK4588","AMR","LU0889565916.HKD","BIIB","BK4139","IE00B19Z9Z06.USD","IE00B894F039.SGD"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":4,"totalSize":200,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BIIB\",params:#limit:5,,,undefined,":[{"date":"2025-05-01","symbol":"BIIB","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":"2025/03","expectedEps":3.34,"defaultRemindTime":1746086400000,"name":null,"time":"Pre-Market","dateTimestamp":1746072000000,"actualEps":null},{"market":"US","date":"2025-02-12","symbol":"BIIB","fiscalQuarterEnding":"2024/12","expectedEps":3.42,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1739336400000,"reportTimeType":"pre","actualEps":3.44},{"market":"US","date":"2024-10-30","symbol":"BIIB","fiscalQuarterEnding":"2024/09","expectedEps":3.77,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1730260800000,"reportTimeType":"pre","actualEps":4.08},{"market":"US","date":"2024-08-01","symbol":"BIIB","fiscalQuarterEnding":"2024/06","expectedEps":4,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1722484800000,"reportTimeType":"pre","actualEps":5.28},{"market":"US","date":"2024-04-24","symbol":"BIIB","fiscalQuarterEnding":"2024/03","expectedEps":3.44,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1713931200000,"reportTimeType":"pre","actualEps":3.67}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BIIB\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BIIB\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.1351,"buy":0.2973,"hold":0.5676,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.2973,"analysts":37,"updateTime":1745035200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/BIIB\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"BIIB","date":"2025-04-21","current":10.63689,"percent":0.207009,"low":7.118871,"twenty":10.544088,"median":14.534807,"eighty":23.766052,"high":29.553699,"avg":16.733727,"sd":6.405489,"marketCap":17361531277},"quantilePoints":[{"date":"2020-04-24","current":8.266523,"twenty":10.091281,"median":18.07454,"eighty":23.708874,"marketCap":48597233330},{"date":"2020-05-01","current":8.135779,"twenty":10.07176,"median":18.012028,"eighty":23.617475,"marketCap":47828620271},{"date":"2020-05-08","current":8.716768,"twenty":10.02851,"median":17.941434,"eighty":23.575195,"marketCap":51244134353},{"date":"2020-05-15","current":8.788385,"twenty":10.005167,"median":17.872053,"eighty":23.523353,"marketCap":51665158067},{"date":"2020-05-22","current":8.453338,"twenty":9.980844,"median":17.845067,"eighty":23.441943,"marketCap":49695485111},{"date":"2020-05-29","current":8.5244,"twenty":9.952875,"median":17.793638,"eighty":23.39973,"marketCap":50113245075},{"date":"2020-06-05","current":8.51413,"twenty":9.935659,"median":17.745054,"eighty":23.331756,"marketCap":50052865705},{"date":"2020-06-12","current":7.752155,"twenty":9.912793,"median":17.717038,"eighty":23.290522,"marketCap":45573369215},{"date":"2020-06-19","current":7.522591,"twenty":9.882941,"median":17.641412,"eighty":23.274583,"marketCap":44223808706},{"date":"2020-06-26","current":7.18005,"twenty":9.839426,"median":17.617939,"eighty":23.20563,"marketCap":42210075128},{"date":"2020-07-02","current":7.35937,"twenty":9.822188,"median":17.60812,"eighty":23.16697,"marketCap":43264266288},{"date":"2020-07-10","current":7.741329,"twenty":9.805832,"median":17.586209,"eighty":23.133447,"marketCap":45509726095},{"date":"2020-07-17","current":7.824605,"twenty":9.778712,"median":17.575932,"eighty":23.10241,"marketCap":45999288553},{"date":"2020-07-24","current":7.274331,"twenty":9.759273,"median":17.556853,"eighty":23.051853,"marketCap":43113507557},{"date":"2020-07-31","current":7.33737,"twenty":9.724919,"median":17.535983,"eighty":22.988205,"marketCap":43487127348},{"date":"2020-08-07","current":8.16596,"twenty":9.705637,"median":17.497244,"eighty":22.876317,"marketCap":48398011219},{"date":"2020-08-14","current":7.731632,"twenty":9.679062,"median":17.45673,"eighty":22.723735,"marketCap":45823834180},{"date":"2020-08-21","current":7.400944,"twenty":9.655614,"median":17.413426,"eighty":22.661849,"marketCap":43863913409},{"date":"2020-08-28","current":7.518207,"twenty":9.632255,"median":17.397112,"eighty":22.587404,"marketCap":44558909547},{"date":"2020-09-04","current":7.372362,"twenty":9.614065,"median":17.378069,"eighty":22.42913,"marketCap":43694517996},{"date":"2020-09-11","current":7.20969,"twenty":9.602867,"median":17.350561,"eighty":22.335607,"marketCap":42730388957},{"date":"2020-09-18","current":7.331761,"twenty":9.586475,"median":17.321151,"eighty":22.255796,"marketCap":43453881520},{"date":"2020-09-25","current":7.299707,"twenty":9.573977,"median":17.284385,"eighty":22.200202,"marketCap":43263905354},{"date":"2020-10-02","current":7.416169,"twenty":9.547468,"median":17.23158,"eighty":22.097473,"marketCap":43954152088},{"date":"2020-10-09","current":7.653901,"twenty":9.532545,"median":17.185087,"eighty":21.967812,"marketCap":45363141980},{"date":"2020-10-16","current":7.479475,"twenty":9.519083,"median":17.144713,"eighty":21.861118,"marketCap":44329355014},{"date":"2020-10-23","current":8.023497,"twenty":9.490154,"median":17.111369,"eighty":21.800014,"marketCap":40778623205},{"date":"2020-10-30","current":7.632011,"twenty":9.440934,"median":17.090104,"eighty":21.717076,"marketCap":38788934155},{"date":"2020-11-06","current":9.95822,"twenty":9.433658,"median":17.00115,"eighty":21.557478,"marketCap":50611657253},{"date":"2020-11-13","current":7.526646,"twenty":9.401534,"median":16.943398,"eighty":21.418296,"marketCap":38253426198},{"date":"2020-11-20","current":7.392215,"twenty":9.374991,"median":16.89913,"eighty":21.324971,"marketCap":37570191907},{"date":"2020-11-27","current":7.381012,"twenty":9.342731,"median":16.867207,"eighty":21.259812,"marketCap":37513255716},{"date":"2020-12-04","current":7.444292,"twenty":9.300913,"median":16.842713,"eighty":21.093244,"marketCap":37834868254},{"date":"2020-12-11","current":7.30986,"twenty":9.204085,"median":16.806989,"eighty":21.039297,"marketCap":37151633963},{"date":"2020-12-18","current":7.557832,"twenty":9.090973,"median":16.745647,"eighty":20.967974,"marketCap":38411924243},{"date":"2020-12-24","current":7.535729,"twenty":9.011245,"median":16.712559,"eighty":20.923425,"marketCap":38299590677},{"date":"2020-12-31","current":7.413712,"twenty":8.881734,"median":16.62625,"eighty":20.871689,"marketCap":37679447841},{"date":"2021-01-08","current":7.646242,"twenty":8.771333,"median":16.5374,"eighty":20.774938,"marketCap":38861258506},{"date":"2021-01-15","current":8.351704,"twenty":8.712798,"median":16.502814,"eighty":20.651824,"marketCap":42446699716},{"date":"2021-01-22","current":8.157929,"twenty":8.604345,"median":16.461569,"eighty":20.586908,"marketCap":41461857495},{"date":"2021-01-29","current":8.556682,"twenty":8.514078,"median":16.392872,"eighty":20.49891,"marketCap":43488478128},{"date":"2021-02-05","current":10.094156,"twenty":8.500791,"median":16.345496,"eighty":20.411283,"marketCap":40382678930},{"date":"2021-02-12","current":10.586888,"twenty":8.500791,"median":16.278386,"eighty":20.374501,"marketCap":42353903289},{"date":"2021-02-19","current":10.599073,"twenty":8.500791,"median":16.233805,"eighty":20.245858,"marketCap":42402650723},{"date":"2021-02-26","current":10.390785,"twenty":8.500791,"median":16.187357,"eighty":20.203066,"marketCap":41569374275},{"date":"2021-03-05","current":10.308155,"twenty":8.497203,"median":16.154964,"eighty":20.174961,"marketCap":41238805739},{"date":"2021-03-12","current":10.133757,"twenty":8.497203,"median":16.125084,"eighty":20.070907,"marketCap":40541108091},{"date":"2021-03-19","current":10.16955,"twenty":8.497203,"median":16.113083,"eighty":19.981443,"marketCap":40684303678},{"date":"2021-03-26","current":10.533578,"twenty":8.500791,"median":16.049312,"eighty":19.941245,"marketCap":42140633266},{"date":"2021-04-01","current":10.612781,"twenty":8.500791,"median":15.98416,"eighty":19.889259,"marketCap":42457491587},{"date":"2021-04-09","current":10.09204,"twenty":8.497203,"median":15.949172,"eighty":19.764693,"marketCap":40374215282},{"date":"2021-04-16","current":10.172575,"twenty":8.497203,"median":15.921399,"eighty":19.722098,"marketCap":40696402032},{"date":"2021-04-23","current":13.128862,"twenty":8.497203,"median":15.875061,"eighty":19.696106,"marketCap":39540193992},{"date":"2021-04-30","current":13.363815,"twenty":8.497203,"median":15.807955,"eighty":19.696106,"marketCap":40247801317},{"date":"2021-05-07","current":13.699247,"twenty":8.497203,"median":15.723881,"eighty":19.696106,"marketCap":41258023690},{"date":"2021-05-14","current":14.007686,"twenty":8.497203,"median":15.670061,"eighty":19.696106,"marketCap":42186946497},{"date":"2021-05-21","current":14.156656,"twenty":8.497203,"median":15.60416,"eighty":19.696106,"marketCap":42635599652},{"date":"2021-05-28","current":13.371313,"twenty":8.497203,"median":15.573174,"eighty":19.696106,"marketCap":40270384530},{"date":"2021-06-04","current":14.304126,"twenty":8.497203,"median":15.557418,"eighty":19.696106,"marketCap":43079736165},{"date":"2021-06-11","current":19.828016,"twenty":8.497203,"median":15.557418,"eighty":19.745578,"marketCap":59716036040},{"date":"2021-06-18","current":19.418098,"twenty":8.497203,"median":15.557418,"eighty":19.755193,"marketCap":58481487090},{"date":"2021-06-25","current":17.393005,"twenty":8.497203,"median":15.567751,"eighty":19.755193,"marketCap":52382514167},{"date":"2021-07-02","current":17.432497,"twenty":8.497203,"median":15.570047,"eighty":19.755193,"marketCap":52501452420},{"date":"2021-07-09","current":17.904403,"twenty":8.497203,"median":15.570047,"eighty":19.755193,"marketCap":53922689260},{"date":"2021-07-16","current":16.227739,"twenty":8.497203,"median":15.570047,"eighty":19.755193,"marketCap":48873082945},{"date":"2021-07-23","current":25.283083,"twenty":8.497203,"median":15.570047,"eighty":19.764693,"marketCap":48495482352},{"date":"2021-07-30","current":25.386422,"twenty":8.497203,"median":15.570047,"eighty":19.810328,"marketCap":48693696831},{"date":"2021-08-06","current":26.417481,"twenty":8.497203,"median":15.570047,"eighty":19.852416,"marketCap":50671370620},{"date":"2021-08-13","current":26.592303,"twenty":8.497203,"median":15.570047,"eighty":19.944153,"marketCap":51006695866},{"date":"2021-08-20","current":26.552677,"twenty":8.497203,"median":15.570047,"eighty":19.994038,"marketCap":50930688810},{"date":"2021-08-27","current":26.665339,"twenty":8.497203,"median":15.570047,"eighty":20.098571,"marketCap":51146787303},{"date":"2021-09-03","current":25.920211,"twenty":8.497203,"median":15.570047,"eighty":20.189206,"marketCap":49717556584},{"date":"2021-09-10","current":23.294779,"twenty":8.497203,"median":15.570047,"eighty":20.204127,"marketCap":44681716545},{"date":"2021-09-17","current":23.324305,"twenty":8.497203,"median":15.570047,"eighty":20.247225,"marketCap":44738349254},{"date":"2021-09-24","current":22.665422,"twenty":8.497203,"median":15.570047,"eighty":20.354794,"marketCap":43474545657},{"date":"2021-10-01","current":22.061705,"twenty":8.497203,"median":15.570047,"eighty":20.406509,"marketCap":42316555805},{"date":"2021-10-08","current":22.208555,"twenty":8.497203,"median":15.570047,"eighty":20.49184,"marketCap":42598229012},{"date":"2021-10-15","current":21.848034,"twenty":8.497203,"median":15.570047,"eighty":20.56935,"marketCap":41906713837},{"date":"2021-10-22","current":25.163145,"twenty":8.497203,"median":15.570047,"eighty":20.652077,"marketCap":38897190137},{"date":"2021-10-29","current":25.341796,"twenty":8.497203,"median":15.570047,"eighty":20.775909,"marketCap":39173348436},{"date":"2021-11-05","current":26.48212,"twenty":8.497203,"median":15.570047,"eighty":20.846596,"marketCap":40936060980},{"date":"2021-11-12","current":25.698147,"twenty":8.497203,"median":15.570047,"eighty":20.923635,"marketCap":39724196106},{"date":"2021-11-19","current":24.43999,"twenty":8.497203,"median":15.570047,"eighty":20.97455,"marketCap":37779336599},{"date":"2021-11-26","current":23.082054,"twenty":8.497203,"median":15.570047,"eighty":21.028174,"marketCap":35680239744},{"date":"2021-12-03","current":21.278442,"twenty":8.497203,"median":15.570047,"eighty":21.079902,"marketCap":32892216071},{"date":"2021-12-10","current":22.105177,"twenty":8.497203,"median":15.570047,"eighty":21.201871,"marketCap":34170182665},{"date":"2021-12-17","current":22.562257,"twenty":8.497203,"median":15.570047,"eighty":21.294992,"marketCap":34876736610},{"date":"2021-12-23","current":22.370302,"twenty":8.497203,"median":15.570047,"eighty":21.362909,"marketCap":34580013331},{"date":"2021-12-31","current":22.798874,"twenty":8.497203,"median":15.570047,"eighty":21.502724,"marketCap":35242499463},{"date":"2022-01-07","current":22.103276,"twenty":8.500791,"median":15.57263,"eighty":21.634937,"marketCap":34167244811},{"date":"2022-01-14","current":22.739957,"twenty":8.500791,"median":15.57263,"eighty":21.738204,"marketCap":35151425981},{"date":"2022-01-21","current":20.955351,"twenty":8.500791,"median":15.57263,"eighty":21.764755,"marketCap":32392780850},{"date":"2022-01-28","current":21.401027,"twenty":8.500791,"median":15.57263,"eighty":21.764755,"marketCap":33081707669},{"date":"2022-02-04","current":20.921964,"twenty":8.500791,"median":15.57263,"eighty":21.790769,"marketCap":32556667533},{"date":"2022-02-11","current":20.266529,"twenty":8.500791,"median":15.57263,"eighty":21.790769,"marketCap":31536745749},{"date":"2022-02-18","current":19.813202,"twenty":8.500791,"median":15.57263,"eighty":21.790769,"marketCap":30831324343},{"date":"2022-02-25","current":19.585595,"twenty":8.500791,"median":15.57263,"eighty":21.790769,"marketCap":30477144012},{"date":"2022-03-04","current":19.781092,"twenty":8.500791,"median":15.57263,"eighty":21.790769,"marketCap":30781356993},{"date":"2022-03-11","current":18.668553,"twenty":8.500791,"median":15.57263,"eighty":21.790769,"marketCap":29050135292},{"date":"2022-03-18","current":19.697982,"twenty":8.500791,"median":15.57263,"eighty":21.790769,"marketCap":30652029736},{"date":"2022-03-25","current":19.924645,"twenty":8.500791,"median":15.57263,"eighty":21.790769,"marketCap":31004740439},{"date":"2022-04-01","current":19.894423,"twenty":8.500791,"median":15.57263,"eighty":21.790769,"marketCap":30957712345},{"date":"2022-04-08","current":20.28164,"twenty":8.500791,"median":15.57263,"eighty":21.790769,"marketCap":31560259796},{"date":"2022-04-14","current":20.073865,"twenty":8.500791,"median":15.57263,"eighty":21.790769,"marketCap":31236941652},{"date":"2022-04-22","current":19.832091,"twenty":8.500791,"median":15.57263,"eighty":21.790769,"marketCap":30860716902},{"date":"2022-04-29","current":19.616341,"twenty":8.500791,"median":15.575787,"eighty":21.790769,"marketCap":30524988504},{"date":"2022-05-06","current":19.558925,"twenty":8.500791,"median":15.608505,"eighty":21.790769,"marketCap":28354574236},{"date":"2022-05-13","current":20.114548,"twenty":8.500791,"median":15.692187,"eighty":21.790769,"marketCap":29160060308},{"date":"2022-05-20","current":20.1691,"twenty":8.500791,"median":15.775496,"eighty":21.790769,"marketCap":29239144395},{"date":"2022-05-27","current":20.830796,"twenty":8.500791,"median":15.860843,"eighty":21.790769,"marketCap":30198405080},{"date":"2022-06-03","current":20.267092,"twenty":8.500791,"median":15.945572,"eighty":21.790769,"marketCap":29381202848},{"date":"2022-06-10","current":19.951902,"twenty":8.500791,"median":15.991048,"eighty":21.790769,"marketCap":28924272567},{"date":"2022-06-17","current":20.380237,"twenty":8.500791,"median":16.09785,"eighty":21.790769,"marketCap":29545229102},{"date":"2022-06-24","current":21.409654,"twenty":8.497203,"median":16.123616,"eighty":21.791778,"marketCap":31037575115},{"date":"2022-07-01","current":21.278325,"twenty":8.497203,"median":16.204744,"eighty":21.791778,"marketCap":30847187498},{"date":"2022-07-08","current":22.103677,"twenty":8.497203,"median":16.239917,"eighty":21.812733,"marketCap":32043700444},{"date":"2022-07-15","current":21.922847,"twenty":8.497203,"median":16.404704,"eighty":21.82315,"marketCap":31781551341},{"date":"2022-07-22","current":14.53456,"twenty":8.497203,"median":16.750724,"eighty":21.836233,"marketCap":29929565943},{"date":"2022-07-29","current":15.155406,"twenty":8.497203,"median":16.750724,"eighty":21.836233,"marketCap":31208011887},{"date":"2022-08-05","current":15.376684,"twenty":8.497203,"median":16.750724,"eighty":21.836233,"marketCap":31663666855},{"date":"2022-08-12","current":15.573297,"twenty":8.497203,"median":16.750724,"eighty":21.836233,"marketCap":32068532256},{"date":"2022-08-19","current":15.087049,"twenty":8.497203,"median":16.750724,"eighty":21.836233,"marketCap":31067252232},{"date":"2022-08-26","current":13.994755,"twenty":8.497203,"median":16.750724,"eighty":21.836233,"marketCap":28818000003},{"date":"2022-09-02","current":13.814351,"twenty":8.497203,"median":16.227739,"eighty":21.836233,"marketCap":28446510603},{"date":"2022-09-09","current":14.928491,"twenty":8.497203,"median":15.671251,"eighty":21.836233,"marketCap":30740747876},{"date":"2022-09-16","current":14.676206,"twenty":8.497203,"median":15.376684,"eighty":21.836233,"marketCap":30221243168},{"date":"2022-09-23","current":13.937674,"twenty":8.497203,"median":15.31326,"eighty":21.836233,"marketCap":28700458435},{"date":"2022-09-30","current":18.815649,"twenty":8.497203,"median":15.210215,"eighty":21.836233,"marketCap":38745183549},{"date":"2022-10-07","current":18.173661,"twenty":8.497203,"median":15.210215,"eighty":21.836233,"marketCap":37423203690},{"date":"2022-10-14","current":18.648633,"twenty":8.497203,"median":15.210215,"eighty":21.836233,"marketCap":38401265627},{"date":"2022-10-21","current":18.858988,"twenty":8.497203,"median":15.210215,"eighty":21.836233,"marketCap":38834428072},{"date":"2022-10-28","current":14.290557,"twenty":8.497203,"median":15.094801,"eighty":21.836233,"marketCap":40938159143},{"date":"2022-11-04","current":14.166396,"twenty":8.497203,"median":15.004599,"eighty":21.836233,"marketCap":40582475675},{"date":"2022-11-11","current":14.549938,"twenty":8.497203,"median":14.858725,"eighty":21.836233,"marketCap":41681206387},{"date":"2022-11-18","current":15.225533,"twenty":8.497203,"median":14.858725,"eighty":21.836233,"marketCap":43616585257},{"date":"2022-11-25","current":15.339138,"twenty":8.497203,"median":14.858725,"eighty":21.836233,"marketCap":43942028430},{"date":"2022-12-02","current":15.024966,"twenty":8.497203,"median":14.794781,"eighty":21.836233,"marketCap":43042019655},{"date":"2022-12-09","current":14.344846,"twenty":8.497203,"median":14.738925,"eighty":21.836233,"marketCap":41093680659},{"date":"2022-12-16","current":14.325242,"twenty":8.497203,"median":14.656474,"eighty":21.836233,"marketCap":41037520111},{"date":"2022-12-23","current":14.032685,"twenty":8.497203,"median":14.636742,"eighty":21.836233,"marketCap":40199431940},{"date":"2022-12-30","current":13.920085,"twenty":8.497203,"median":14.607243,"eighty":21.836233,"marketCap":39876868795},{"date":"2023-01-06","current":14.037209,"twenty":8.497203,"median":14.549938,"eighty":21.836233,"marketCap":40212392067},{"date":"2023-01-13","current":14.47906,"twenty":8.497203,"median":14.529831,"eighty":21.836233,"marketCap":41478164408},{"date":"2023-01-20","current":14.364953,"twenty":8.497203,"median":14.481071,"eighty":21.836233,"marketCap":41151281221},{"date":"2023-01-27","current":14.581606,"twenty":8.497203,"median":14.481071,"eighty":21.812733,"marketCap":41771927272},{"date":"2023-02-03","current":14.257381,"twenty":8.497203,"median":14.452921,"eighty":21.766456,"marketCap":40843118216},{"date":"2023-02-10","current":14.391595,"twenty":8.497203,"median":14.434492,"eighty":21.713568,"marketCap":41227601965},{"date":"2023-02-17","current":13.20093,"twenty":8.497203,"median":14.416076,"eighty":21.633442,"marketCap":40221914133},{"date":"2023-02-24","current":12.804494,"twenty":8.497203,"median":14.383753,"eighty":21.580551,"marketCap":39014014132},{"date":"2023-03-03","current":12.81635,"twenty":8.497203,"median":14.348868,"eighty":21.467685,"marketCap":39050135544},{"date":"2023-03-10","current":12.166214,"twenty":8.497203,"median":14.307145,"eighty":21.413931,"marketCap":37069237337},{"date":"2023-03-17","current":12.47919,"twenty":8.497203,"median":14.275339,"eighty":21.363363,"marketCap":38022842601},{"date":"2023-03-24","current":12.804969,"twenty":8.497203,"median":14.24783,"eighty":21.306875,"marketCap":39015458989},{"date":"2023-03-31","current":13.184333,"twenty":8.500791,"median":14.205292,"eighty":21.276954,"marketCap":40171344157},{"date":"2023-04-06","current":13.466959,"twenty":8.500791,"median":14.152478,"eighty":21.176842,"marketCap":41032478607},{"date":"2023-04-14","current":13.737731,"twenty":8.497203,"median":14.096524,"eighty":21.070262,"marketCap":41857491646},{"date":"2023-04-21","current":13.76476,"twenty":8.497203,"median":14.07932,"eighty":21.005659,"marketCap":41939848464},{"date":"2023-04-28","current":13.578317,"twenty":8.497203,"median":14.037209,"eighty":21.003669,"marketCap":42513709824},{"date":"2023-05-05","current":14.495964,"twenty":8.497203,"median":14.037209,"eighty":21.003669,"marketCap":45386864333},{"date":"2023-05-12","current":14.356816,"twenty":8.497203,"median":14.037209,"eighty":21.003669,"marketCap":44951189806},{"date":"2023-05-19","current":14.120586,"twenty":8.497203,"median":14.037209,"eighty":21.003669,"marketCap":44211556305},{"date":"2023-05-26","current":13.735963,"twenty":8.497203,"median":14.01426,"eighty":21.003669,"marketCap":43007299803},{"date":"2023-06-02","current":13.980051,"twenty":8.497203,"median":13.992973,"eighty":20.997841,"marketCap":43771539506},{"date":"2023-06-09","current":14.279151,"twenty":8.497203,"median":13.96784,"eighty":20.929644,"marketCap":44708022627},{"date":"2023-06-16","current":13.768323,"twenty":8.497203,"median":13.941165,"eighty":20.892332,"marketCap":43108619461},{"date":"2023-06-23","current":13.588955,"twenty":8.493614,"median":13.935626,"eighty":20.867377,"marketCap":42547019073},{"date":"2023-06-30","current":13.042531,"twenty":8.490026,"median":13.890459,"eighty":20.867651,"marketCap":40836164283},{"date":"2023-07-07","current":13.174745,"twenty":8.490026,"median":13.868177,"eighty":20.815502,"marketCap":41250127456},{"date":"2023-07-14","current":12.850219,"twenty":8.490026,"median":13.817874,"eighty":20.73251,"marketCap":40234036032},{"date":"2023-07-21","current":12.699051,"twenty":8.490026,"median":13.806693,"eighty":20.629889,"marketCap":39760728489},{"date":"2023-07-28","current":14.282866,"twenty":8.490026,"median":13.794619,"eighty":20.526137,"marketCap":38058124204},{"date":"2023-08-04","current":14.552446,"twenty":8.490026,"median":13.794619,"eighty":20.460449,"marketCap":38776447946},{"date":"2023-08-11","current":14.623646,"twenty":8.490026,"median":13.794619,"eighty":20.395995,"marketCap":38966166515},{"date":"2023-08-18","current":14.212753,"twenty":8.490026,"median":13.794619,"eighty":20.321644,"marketCap":37871302102},{"date":"2023-08-25","current":14.263299,"twenty":8.490026,"median":13.794619,"eighty":20.266979,"marketCap":38005987804},{"date":"2023-09-01","current":14.531249,"twenty":8.486438,"median":13.786176,"eighty":20.242472,"marketCap":38719966845},{"date":"2023-09-08","current":14.204057,"twenty":8.486438,"median":13.786176,"eighty":20.208919,"marketCap":37848130368},{"date":"2023-09-15","current":13.931216,"twenty":8.486438,"median":13.786176,"eighty":20.198211,"marketCap":37121117227},{"date":"2023-09-22","current":14.073071,"twenty":8.486438,"median":13.776523,"eighty":20.143845,"marketCap":37499106131},{"date":"2023-09-29","current":14.013285,"twenty":8.486438,"median":13.776523,"eighty":20.072921,"marketCap":37339800463},{"date":"2023-10-06","current":14.118726,"twenty":8.486438,"median":13.768434,"eighty":19.9917,"marketCap":37620757732},{"date":"2023-10-13","current":14.185034,"twenty":8.486438,"median":13.768434,"eighty":19.951902,"marketCap":37797442201},{"date":"2023-10-20","current":13.98448,"twenty":8.486438,"median":13.768434,"eighty":19.927657,"marketCap":37263044095},{"date":"2023-10-27","current":13.102908,"twenty":8.47807,"median":13.76476,"eighty":19.922756,"marketCap":34914009601},{"date":"2023-11-03","current":13.145302,"twenty":8.47807,"median":13.737731,"eighty":19.916955,"marketCap":35026971803},{"date":"2023-11-10","current":22.267999,"twenty":8.47807,"median":13.71992,"eighty":19.89329,"marketCap":32551360860},{"date":"2023-11-17","current":22.744781,"twenty":8.47807,"median":13.71992,"eighty":19.905271,"marketCap":33248320779},{"date":"2023-11-24","current":22.991597,"twenty":8.47807,"median":13.71992,"eighty":19.905271,"marketCap":33609117078},{"date":"2023-12-01","current":23.20273,"twenty":8.47807,"median":13.71992,"eighty":19.905271,"marketCap":33917750056},{"date":"2023-12-08","current":23.70231,"twenty":8.48086,"median":13.727942,"eighty":19.915471,"marketCap":34648036541},{"date":"2023-12-14","current":25.331893,"twenty":8.48086,"median":13.727942,"eighty":19.915471,"marketCap":37030161502},{"date":"2023-12-22","current":25.163384,"twenty":8.475281,"median":13.713268,"eighty":19.929934,"marketCap":36783834712},{"date":"2023-12-29","current":25.829491,"twenty":8.470794,"median":13.704438,"eighty":19.950281,"marketCap":37757550024},{"date":"2024-01-05","current":25.799754,"twenty":8.469944,"median":13.703558,"eighty":19.987922,"marketCap":37714080591},{"date":"2024-01-12","current":24.504216,"twenty":8.469944,"median":13.703558,"eighty":19.987922,"marketCap":35820262267},{"date":"2024-01-19","current":24.480426,"twenty":8.469095,"median":13.702678,"eighty":19.980718,"marketCap":35785486720},{"date":"2024-01-26","current":24.405092,"twenty":8.469944,"median":13.703558,"eighty":19.987922,"marketCap":35675364155},{"date":"2024-02-02","current":24.565672,"twenty":8.469944,"median":13.703558,"eighty":20.065327,"marketCap":35910099096},{"date":"2024-02-09","current":23.819275,"twenty":8.469944,"median":13.703558,"eighty":20.158998,"marketCap":34819016313},{"date":"2024-02-16","current":27.961704,"twenty":8.469944,"median":13.703558,"eighty":20.245941,"marketCap":32466334233},{"date":"2024-02-23","current":27.852786,"twenty":8.469944,"median":13.703558,"eighty":20.275821,"marketCap":32339870339},{"date":"2024-03-01","current":27.165481,"twenty":8.470794,"median":13.704438,"eighty":20.331364,"marketCap":31541839558},{"date":"2024-03-08","current":27.462186,"twenty":8.470794,"median":13.704438,"eighty":20.459236,"marketCap":31886344649},{"date":"2024-03-15","current":27.494736,"twenty":8.470794,"median":13.71992,"eighty":20.628123,"marketCap":31924138456},{"date":"2024-03-22","current":27.636204,"twenty":8.470794,"median":13.735963,"eighty":20.786154,"marketCap":32088396158},{"date":"2024-03-28","current":27.084106,"twenty":8.470794,"median":13.752143,"eighty":20.831794,"marketCap":31447355039},{"date":"2024-04-05","current":25.701982,"twenty":8.469944,"median":13.77193,"eighty":20.907169,"marketCap":29842571829},{"date":"2024-04-12","current":25.499171,"twenty":8.469944,"median":13.808789,"eighty":21.038884,"marketCap":29607087336},{"date":"2024-04-19","current":23.85164,"twenty":8.469944,"median":13.85217,"eighty":21.289275,"marketCap":27694139234},{"date":"2024-04-26","current":25.267913,"twenty":8.470794,"median":13.868177,"eighty":21.404478,"marketCap":29477547361},{"date":"2024-05-03","current":26.647002,"twenty":8.470794,"median":13.908932,"eighty":21.47563,"marketCap":31086393051},{"date":"2024-05-10","current":27.800196,"twenty":8.470794,"median":13.937674,"eighty":21.648875,"marketCap":32431708361},{"date":"2024-05-17","current":28.71002,"twenty":8.470794,"median":13.950238,"eighty":21.782935,"marketCap":33493109725},{"date":"2024-05-24","current":27.214863,"twenty":8.470794,"median":13.980051,"eighty":21.877959,"marketCap":31748858923},{"date":"2024-05-31","current":27.46572,"twenty":8.470794,"median":13.994755,"eighty":22.000262,"marketCap":32041508682},{"date":"2024-06-07","current":28.953389,"twenty":8.470794,"median":14.01426,"eighty":22.073132,"marketCap":33777023671},{"date":"2024-06-14","current":29.184277,"twenty":8.469944,"median":14.041825,"eighty":22.114991,"marketCap":34046377926},{"date":"2024-06-21","current":28.153392,"twenty":8.469095,"median":14.072528,"eighty":22.189441,"marketCap":32843747574},{"date":"2024-06-28","current":28.545278,"twenty":8.464282,"median":14.07812,"eighty":22.231423,"marketCap":33300921824},{"date":"2024-07-05","current":28.032332,"twenty":8.464282,"median":14.08367,"eighty":22.274713,"marketCap":32702518585},{"date":"2024-07-12","current":29.553699,"twenty":8.464282,"median":14.11215,"eighty":22.314226,"marketCap":34477344736},{"date":"2024-07-15","current":28.712516,"twenty":8.464282,"median":14.119656,"eighty":22.340794,"marketCap":33496021663},{"date":"2024-08-02","current":26.48965,"twenty":8.513869,"median":14.166396,"eighty":22.380755,"marketCap":30690907969},{"date":"2024-08-09","current":25.656112,"twenty":8.592131,"median":14.204057,"eighty":22.479723,"marketCap":29725171282},{"date":"2024-08-16","current":25.34935,"twenty":8.71649,"median":14.24783,"eighty":22.562257,"marketCap":29369756876},{"date":"2024-08-23","current":25.56182,"twenty":8.771928,"median":14.263299,"eighty":22.739957,"marketCap":29615925051},{"date":"2024-08-30","current":25.750404,"twenty":8.883073,"median":14.292141,"eighty":22.781193,"marketCap":29834417514},{"date":"2024-09-06","current":25.370723,"twenty":9.022005,"median":14.304126,"eighty":22.950917,"marketCap":29394519355},{"date":"2024-09-13","current":24.879149,"twenty":9.165962,"median":14.325242,"eighty":22.991597,"marketCap":28824982335},{"date":"2024-09-20","current":25.325463,"twenty":9.324413,"median":14.348868,"eighty":23.181914,"marketCap":29342081164},{"date":"2024-09-27","current":24.339801,"twenty":9.391209,"median":14.369659,"eighty":23.258238,"marketCap":28200093891},{"date":"2024-10-04","current":23.230932,"twenty":9.429088,"median":14.383753,"eighty":23.324305,"marketCap":26915358208},{"date":"2024-10-11","current":23.709934,"twenty":9.504668,"median":14.406786,"eighty":23.460277,"marketCap":27470329064},{"date":"2024-10-18","current":23.830627,"twenty":9.553828,"median":14.419745,"eighty":23.728792,"marketCap":27610164241},{"date":"2024-10-25","current":23.115268,"twenty":9.604326,"median":14.473094,"eighty":23.76148,"marketCap":26781349498},{"date":"2024-10-31","current":16.34561,"twenty":9.604326,"median":14.485595,"eighty":23.76148,"marketCap":26401430021},{"date":"2024-11-08","current":15.690631,"twenty":9.628672,"median":14.521195,"eighty":23.763004,"marketCap":25343507612},{"date":"2024-11-15","current":14.875967,"twenty":9.644632,"median":14.532646,"eighty":23.763004,"marketCap":24027661972},{"date":"2024-11-22","current":14.255271,"twenty":9.699532,"median":14.532646,"eighty":23.763004,"marketCap":23025112913},{"date":"2024-11-29","current":14.49164,"twenty":9.699532,"median":14.532646,"eighty":23.763004,"marketCap":23406897584},{"date":"2024-12-06","current":14.368042,"twenty":9.707445,"median":14.533753,"eighty":23.763004,"marketCap":23207262088},{"date":"2024-12-13","current":14.013488,"twenty":9.707445,"median":14.533753,"eighty":23.763004,"marketCap":22634585082},{"date":"2024-12-20","current":13.29716,"twenty":9.707445,"median":14.533753,"eighty":23.763004,"marketCap":21477573522},{"date":"2024-12-27","current":13.523606,"twenty":9.707445,"median":14.533753,"eighty":23.763004,"marketCap":21843329066},{"date":"2025-01-03","current":13.532628,"twenty":9.707445,"median":14.533753,"eighty":23.763004,"marketCap":21857901000},{"date":"2025-01-10","current":13.600291,"twenty":9.764574,"median":14.53456,"eighty":23.764528,"marketCap":21967190505},{"date":"2025-01-17","current":12.74142,"twenty":9.816223,"median":14.53456,"eighty":23.764528,"marketCap":20579942388},{"date":"2025-01-24","current":12.961551,"twenty":9.886141,"median":14.53456,"eighty":23.764528,"marketCap":20935497577},{"date":"2025-01-31","current":13.192508,"twenty":9.95619,"median":14.53456,"eighty":23.764528,"marketCap":21308539088},{"date":"2025-02-07","current":12.844268,"twenty":9.977934,"median":14.53456,"eighty":23.764528,"marketCap":20746062435},{"date":"2025-02-14","current":12.416132,"twenty":10.002015,"median":14.53456,"eighty":23.764528,"marketCap":20265610027},{"date":"2025-02-21","current":12.293271,"twenty":10.031403,"median":14.53456,"eighty":23.764528,"marketCap":20065076363},{"date":"2025-02-28","current":12.544373,"twenty":10.117917,"median":14.53456,"eighty":23.764528,"marketCap":20474926187},{"date":"2025-03-07","current":13.216073,"twenty":10.153098,"median":14.534807,"eighty":23.766052,"marketCap":21571274465},{"date":"2025-03-14","current":12.553341,"twenty":10.179175,"median":14.534807,"eighty":23.766052,"marketCap":20489563681},{"date":"2025-03-21","current":12.678893,"twenty":10.263071,"median":14.534807,"eighty":23.766052,"marketCap":20694488593},{"date":"2025-03-28","current":12.584729,"twenty":10.356971,"median":14.534807,"eighty":23.766052,"marketCap":20540794909},{"date":"2025-04-04","current":11.722012,"twenty":10.485219,"median":14.534807,"eighty":23.766052,"marketCap":19132668015},{"date":"2025-04-11","current":10.167866,"twenty":10.511569,"median":14.53456,"eighty":23.764528,"marketCap":16595990357},{"date":"2025-04-17","current":10.339154,"twenty":10.525201,"median":14.53456,"eighty":23.764528,"marketCap":16875566486},{"date":"2025-04-21","current":10.63689,"twenty":10.544088,"median":14.534807,"eighty":23.766052,"marketCap":17361531277}],"updateTime":1745320341359}}}